Zoetis (ZTS) Revenue (2012 - 2026)
Zoetis' (ZTS) quarterly Revenue came in at $2.3 billion in Q1 2026, up 2.91% year-on-year from $2.2 billion in Q1 2025, and down 5.24% on a QoQ basis from $2.4 billion in Q4 2025.
Zoetis (ZTS) Revenue (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Revenue data on file, last reported at $2.3 billion in Q1 2026.
- On a quarterly basis, Revenue rose 2.91% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $9.5 billion, a 2.64% increase from a year earlier, with the FY2025 full-year figure at $9.5 billion, up 2.28% from the prior year.
- Revenue for Q1 2026 stood at $2.3 billion, down from $2.4 billion in the prior quarter.
- Over the last five years, Revenue for ZTS reached as high as $2.5 billion in Q2 2025 and fell as low as $2.0 billion in Q1 2022.
- Historically, Revenue has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2025.
- Across the five-year window, Revenue grew 11.02% in 2024 and grew 0.37% in 2025, its largest moves.
- Year by year, Revenue stood at $2.0 billion in 2022, then climbed by 8.48% to $2.2 billion in 2023, then advanced by 4.7% to $2.3 billion in 2024, then advanced by 3.02% to $2.4 billion in 2025, then dropped by 5.24% to $2.3 billion in 2026.
- Per Business Quant data, the three most recent Revenue figures were $2.3 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 106.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Bn |
| Dec 31, 2025 | 2.39 Bn |
| Sep 30, 2025 | 2.40 Bn |
| Jun 30, 2025 | 2.46 Bn |
| Mar 31, 2025 | 2.20 Bn |
| Dec 31, 2024 | 2.32 Bn |
| Sep 30, 2024 | 2.39 Bn |
| Jun 30, 2024 | 2.36 Bn |
| Mar 31, 2024 | 2.19 Bn |
| Dec 31, 2023 | 2.21 Bn |
| Sep 30, 2023 | 2.15 Bn |
| Jun 30, 2023 | 2.18 Bn |
| Mar 31, 2023 | 2.00 Bn |
| Dec 31, 2022 | 2.04 Bn |
| Sep 30, 2022 | 2.00 Bn |
| Jun 30, 2022 | 2.05 Bn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | 1.97 Bn |
| Sep 30, 2021 | 1.99 Bn |
| Jun 30, 2021 | 1.95 Bn |